Hemorrhages during escitalopram-venlafaxine-mirtazapine combination treatment of depression [1]

Canadian Journal of Psychiatry

Volumn 50, Issue 3, 2005, Pages 184-

  Benazzi, Franco ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ESCITALOPRAM; IRBESARTAN; MIRTAZAPINE; OMEPRAZOLE; SEROTONIN UPTAKE INHIBITOR; VENLAFAXINE;

ADULT; BLEEDING; CASE REPORT; DEPRESSION; EPISTAXIS; HUMAN; LETTER; MALE; RECTUM HEMORRHAGE; THROMBOCYTE AGGREGATION; THROMBOCYTE RELEASE REACTION;

EID: 17144364719     PISSN: 07067437     EISSN: None     Source Type: Journal    
DOI: 10.1177/070674370505000314     Document Type: Letter

References (5)

1. de Abajo FJ, Rodriguez LA, Montero D. Association between selective serotonin reuptake inhibitors and upper gastrointestinal bleeding: population based case-control study. BMJ 1999;319:1106-9.
2. Layton D, Clark DW, Pearce GL, Shakir SA. Is there an association between selective serotonin reuptake inhibitors and risk of abnormal bleeding? Results from a cohort study based on prescription event monitoring in England. Eur J Clin Pharmacol 2001;57:167-76.
3. Dalton SO, Johansen C, Mellemkjaer L, Norgard B, Sorensen HT, Olsen JH. Use of selective serotonin reuptake inhibitors and risk of upper gastrointestinal tract bleeding: a population-based cohort study. Arch Intern Med 2003;163:59-64.
4. Cozza KL, Armstrong SC, Oesterheld JR. Drug interaction principles for medical practice. Washington (DC): American Psychiatric Association; 2003.
5. Baldessarini RJ. Drugs and the treatment of psychiatric disorders. Depression and anxiety. In: Hardman JG, Limbird LE, Goodman Gilman A, editors. Goodman & Gilman's the pharmacological basis of therapeutics. 10th ed. New York: McGraw-Hill; 2001. p 447-83.